| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q4 2021 Pre-Market | EPS: REV: | ||||
| Q3 2021 Pre-Market | EPS: REV: | 2.92 29.941B | |||
| Q2 2021 Pre-Market | EPS: REV: | ||||
| Q1 2021 Pre-Market | EPS: REV: | 2.89 29.069B | |||
| Q4 2020 Pre-Market | EPS: REV: | 2.57 29.211B | 2.62 28.7B | 3.79 30.161B | 44.66% 5.09% |
| Q3 2020 Pre-Market | EPS: REV: | 2.68 30.064B | 2.23 28.29B | 2.92 29.941B | 30.94% 5.84% |
| Q2 2020 Pre-Market | EPS: REV: | 2.59 29.566B | 1.04 30.29B | 1.38 33.817B | 32.69% 11.64% |
| Q1 2020 Pre-Market | EPS: REV: | 2.65 29.851B | 1.84 29.67B | 2.89 29.069B | 57.07% -2.03% |
| Q4 2019 Pre-Market | EPS: REV: | 1.98 26.804B | 2.35 27.96B | 2.57 29.211B | 9.36% 4.47% |
| Q3 2019 Pre-Market | EPS: REV: | 2.34 27.822B | 2.45 28.49B | 2.68 30.064B | 9.39% 5.52% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- Global Ship Lease: Q4 Earnings Insights
- Ranpak Holdings: Q4 Earnings Insights
- Kroger: Q4 Earnings Insights
- Recap: CRA International Q4 Earnings
- Toro: Q1 Earnings Insights
- Purple Innovation: Q4 Earnings Insights
- Recap: Marcus Q4 Earnings
- The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
- Recap: Arbutus Biopharma Q4 Earnings
- Recap: Syros Pharmaceuticals Q4 Earnings
